In vitro Engineering of Novel Bioactivity in the Natural Enzymes by Vishvanath Tiwari
MINI REVIEW
published: 07 October 2016
doi: 10.3389/fchem.2016.00039
Frontiers in Chemistry | www.frontiersin.org 1 October 2016 | Volume 4 | Article 39
Edited by:
Qi Zhang,
Fudan University, China
Reviewed by:
Yi Yu,
Wuhan University, China
Haijun Liu,
Washington University in St. Louis,
USA
*Correspondence:
Vishvanath Tiwari
vishvanath7@yahoo.co.in
Specialty section:
This article was submitted to
Protein Chemistry and Enzymology,
a section of the journal
Frontiers in Chemistry
Received: 12 June 2016
Accepted: 21 September 2016
Published: 07 October 2016
Citation:
Tiwari V (2016) In vitro Engineering of
Novel Bioactivity in the Natural
Enzymes. Front. Chem. 4:39.
doi: 10.3389/fchem.2016.00039
In vitro Engineering of Novel
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Enzymes catalyze various biochemical functions with high efficiency and specificity.
In vitro design of the enzyme leads to novel bioactivity in this natural biomolecule that give
answers of some vital questions like crucial residues in binding with substrate, molecular
evolution, cofactor specificity etc. Enzyme engineering technology involves directed
evolution, rational designing, semi-rational designing, and structure-based designing
using chemical modifications. Similarly, combined computational and in vitro evolution
approaches together help in artificial designing of novel bioactivity in the natural enzyme.
DNA shuffling, error prone PCR and staggered extension process are used to artificially
redesign active site of enzyme, which can alter its efficiency and specificity. Modifications
of the enzyme can lead to the discovery of new path of molecular evolution, designing
of efficient enzymes, locating active sites and crucial residues, shift in substrate, and
cofactor specificity. Themethods and thermodynamics of in vitro designing of the enzyme
are also discussed. Similarly, engineered thermophilic and psychrophilic enzymes attain
substrate specificity and activity of mesophilic enzymes that may also be beneficial for
industry and therapeutics.
Keywords: in vitro design, strategic manipulation, molecular evolution, novel bioactivity of natural enzyme,
thermodynamics of in vitro design
INTRODUCTION
Enzymes are the biocatalysts that have specificity, efficiency, and mode of regulation. They are also
used for varied industrial processes especially in medical research such as de novo drug discovery
and its improvement (increase the yield of antibiotics, hormones, etc.), crop improvement, biofuel
industry, food industry, etc. Enzymes used in biotechnological process have to be very efficient
in their catalytic activity because in vivo and in vitro conditions are very different. Most of
the enzymes are derived from mesophilic organisms; hence they are most active in moderate
conditions. Therefore, in order to improve the catalytic performance of the industrial enzymes and
withstand harsh conditions, protein engineering plays amajor role, and resulting in the reduction of
cost and time of processing in the respective industries. Changing cofactor specificity, discovering
path of molecular evolution, designing more powerful and efficient enzymes, locating active sites
and crucial residues, shifting the substrate specificity toward new substrate, improving binding
affinity, changing in pH tolerance and inhibitor tolerance, improving solubility and resistance
to extreme conditions, are some of the modifications that can be achieved by in vitro enzyme
designing. Enzymes can be altered by redesigning the active site that can alter its efficiency (kcat/km)
and specificity (km). Altering the ligand binding sites, incorporation of new functional groups
into the active site, DNA shuﬄing, site-saturation, and site-directed mutagenesis are some of
the approaches that modify the active site of an enzyme. Thermo-stabilizing traits such as high
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number of hydrogen bonds, introduction of ion pairs for linking
of N and C-terminals, addition of proline residues in loops are
among many modifications that can be achieved at genetic level
through mutagenesis after complete analysis of sequence and
structure of homologous mesophilic and thermophilic enzymes.
Cryo-stabilizing characteristics such as clustering of glycine
residues which provide local flexibility in the region, reduced
frequency of proline residues in loops leading to enhanced chain
flexibility between secondary structures, a reduction in arginine
residues which generally participate in formation of multiple salt
bridges and H-bonds, and a lowered number of ion pairs and
aromatic interactions, can also be introduced by mutagenesis.
These characteristics of thermophilic and cryophilic enzyme can
be added in the mesophilic enzyme.
Theodosius Dobzhansky stated that “Nothing in biology
makes sense except in the light of evolution” (Dobzhansky, 1973).
Evolution is the change in heritable phenotypic trait of biological
population over successive generations. The amazing similarity
in gene sequences and metabolic pathways across the phyla says
that modern organisms are derived from common progenitor
by series of small changes, i.e., mutations. Homology means two
proteins are descended from a common ancestor while sequence
homology means amino acids at equivalent positions are similar
because they are descended from a common ancestor (Hall and
Barlow, 2004). The gradual accumulation of mutations over long
period of time results in the formation of new species. Natural
in vivo design of the bioactivity leads to the molecular evolution.
Molecular evolution is a fundamental biological process and its
understanding would facilitate the engineering of enzymes with
new specificities. During the course of evolution, it is possible
that inefficient enzymes convert to efficient enzymes or vice-versa
FIGURE 1 | Summary of enzyme engineering methods and their significances.
(Geddie and Matsumura, 2004). The in vitro design of the
activity can be done using various mutagenesis approaches. Thus,
enzyme engineering using in vitro approaches may contribute
to elucidate structural basis of the functional properties, and the
course of the natural molecular evolution. In the present review,
we have explained the methods for In vitro mutagenesis and
their significances in the enzyme substrate replacement, cofactor
replacement, and change in enzyme catalysis.
METHODS FOR IN VITRO DESIGN OR
ARTIFICIAL MUTATION
Protein engineering technology (Figure 1) involves directed
evolution, rational designing, semi-rational design, structure-
based design using chemical modification, and truncated and
fusion methods (Li and Cirino, 2014; Kaushik et al., 2016). In
directed evolution, natural evolution is mimicked in the lab and
based on developing molecular diversity by randommutagenesis
and in vitro recombination followed by performing high-
throughput screening for improvements in desired phenotype.
Similarly, rational protein design is used for those enzymes whose
three-dimensional structures have already been determined
and site-directed mutagenesis is used to introduce specific
and deliberate mutations on the enzyme sites. Both directed
evolution and rational protein design have certain limitations,
hence a combined approach known as semi-rational design,
takes advantage of already available information of structure
and function of the desired protein and designs a smaller but
higher quality library. Molecular dynamics and QM studies also
compliment such studies as they facilitate the understanding
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about the impact of every single amino acid on the structure
and function of the protein. This computer-guided semi-rational
designing of proteins further helps in shaping the needs of a good
biocatalyst with a larger substrate range, selectivity, specificity,
and stability without harming their catalytic efficiency (Kaushik
et al., 2016).
Recent studies have shown that combined computational
and in vitro evolution approaches can be used for the study
of evolution of novel bioactivity in the natural enzymes.
In vitro study can be achieved by construction of large libraries
of protein/enzyme mutants, enzyme with certain substrate
binding characteristics are selected, and the sequences of the
selected enzyme are determined. The main advantage of this
method is that they require minimal knowledge of enzyme
substrate interaction under study. This method does not provide
much information about the nature of intermolecular contacts,
which often hampers an understanding of the obtained results.
Computational protein design is parallel approach that is based
on our understanding of the biophysical forces that govern
enzyme-substrate binding but it require a detailed knowledge of
the structure and function of the enzyme substrate under study
(Rosenfeld et al., 2016).
Other approach using novel scaffolding and
compartmentalization techniques are also used to improve
performance of enzyme (Li and Cirino, 2014). Consensus design
is another approach that can be used to artificial designing
of enzyme, which is based on the hypothesis that at a given
position of enzyme, the respective consensus amino acid
contributes more than average to the stability of the enzyme than
non-conserved amino acids. Consensus design, like ancestral
sequence reconstruction, utilizes evolutionary history; all
sequences are aligned, and most frequently observed amino acid
is identified at each position in the alignment (Porebski and
Buckle, 2016). To achieve the molecular evolution of a protein,
a consensus library for directed evolution experiments could
be made, which would contain information about site-directed
mutations of a particular protein. This mimics the natural
Darwininan evolution process, which involves repeated cycles of
mutation, followed by selection that renders a strong algorithm
to create diversity as exhibited by the plethora of life. The process
can be performed in vitro by introducing random mutations on
template strand, followed by screening and selection of desired
mutant clones. The whole procedure is repeated until desired
mutation is achieved. Selection or screening of a consensus
library should reveal correlative or co-varying substitutions that
change parallel in order to alter protein function (Flores and
Ellington, 2005). Redesigning of enzymes does not only require
change in the residues that bind to substrates and cofactor but
also requires residues that are far from active site but important
to maintain catalytic residues in prerequisite orientations.
Electrostatic charge distribution throughout a whole enzyme
molecule may also facilitate substrate binding by electrostatically
guiding the substrate into the active site (Oue et al., 1999). The
mutagenized gene library is made by various methods such as
DNA shuﬄing, error prone PCR (ePCR) and staggered extension
process (StEP). However, the efficiency rate of directed evolution
is low and less yield of the final PCR product acts as a drawback
for the downstream processing. This can be avoided using
ExoSAP-IT PCR Product Cleanup (Affymetrix), that serves as an
alternative to beads based PCR (Goh et al., 2012).
ePCR incorporates error in the final product during DNA
amplification. Errors are introduced by altering the parameters
of PCR such as use of high concentrations of magnesium
or manganese, DNA polymerase not capable of proofreading,
increase in the number of amplification cycles and/or biased
concentration of dNTPs. DNA shuﬄing is one of the most
important directed evolution techniques which has increased
the catalytic efficiency of various industrial enzymes namely
β- 1,3- 1,4-glucanase (Yan et al., 2006), glucose dehydogenase
(Gruber et al., 1998) etc. This technique involves formation
of various chimeras by joining different homologous genes via
self-priming PCR and ultimately creating a library. More than
80% similarities should be there in homologous parent genes
(Brakmann and Schwienhorst, 2004). StEP is also a commonly
used homology-dependent process for performing in vitro DNA
recombination. For the purpose of efficient recombination the
parental genes must share more than 85% sequence identity
(Volkov and Arnold, 2000).
Recently, mutagenesis methods have improved tremendously
in comparison to earlier laborious primer extension methods
that require templates (to be mutated) in single stranded
form as well as stringent screening procedures for selection
of mutants. Advance methods such as Exsite and GeneTailor
uses double stranded template DNA and PCR to mutate the
targets followed by easy selection of mutants. Alanine scan
is a standard method to analyze the active site mechanism
and identify the role of important residues, where the
concerned residues are mutated with alanine (Dembowski and
Kantrowitz, 1994). Hence with the types of technologies available
today and with the widely accessible information (web based
databases), engineering procedures have become routine and
are continuously introducing new enzymes and proteins into
market with enhanced traits or novel properties for therapeutic,
pharmaceutical and industrial applications. In vitro mutagenesis
results from the three type of changes i.e., enzyme substrate
replacement, cofactor replacement, and change in enzyme
catalysis. We have critically analyzes each of these in detail by
taking examples of different enzymes. Various enzymes and their
mutants formed by site-directed mutagenesis along with the
mutation sites are listed in Table 1.
SIGNIFICANCE OF IN VITRO
MANIPULATION
Replacement of Natural Substrate with a
Novel Substrate
The alteration in the substrate specificity is seen mainly in the
dehydrogenases. The reason might be the utilization of similar
cofactor i.e., NAD by all dehydrogenases. Malate dehydrogenase
(MDH) from Escherichia coli is highly specific for its keto
acid substrate. The replacement of one of the binding arginine
residues (81st position) with unnatural aryl and alkyl amino
acid analogs, result into enhancement of the specificity of
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MDH for phenyl pyruvate while diminished for oxaloacetate
(physiological substrate; Wright et al., 2000). This is performed
by site-specific modulation that incorporates systemic structural
information at the target site. Similarly, some experiments
also revealed that three arginines (80th, 87th, and 153th) of
malate dehydrogenase are responsible for selectivity of the
substrate. Site-directed mutagenesis at Arg153Cys was done
which decreased its specificity for malate and oxaloacetate. This
substitution changed the conformation of the active site and
thus the specificity for original substrate decreased. Substitutions
of functional group like acetamide etc. changed the substrate
specificity to pyruvate, alpha-ketoglutarate etc. (Bell et al., 2001;
Wright and Viola, 2001).
Some other studies reported that a single amino acid
mutation (Tyr52Leu) was done in NAD-dependent D-lactate
dehydrogenase of Lactobacillus pentosus, resulted in the
increased affinity of enzyme toward larger aliphatic or aromatic
2-ketoacid substrates by four-fold as well as decreased affinity
toward pyruvate (which is its actual substrate) by about 30-fold
and thus converting the enzyme into D-2-hydroxyisocaproate
dehydrogenase (an active enzyme; Tokuda et al., 2003).
Likewise, many attempts have been made to redesign the
active sites of enzymes such as lactate dehydrogenase (LDH)
present in Trichomonas vaginalis (Tv). It resembles malate
dehydrogenase (cytosolic) more closely than LDH of other
species. The Arg at 91st position of MDH was replaced by Leu
in TvLDH. The change Leu91Arg was done by site directed
mutagenesis that converted TvLDH to MDH. The reverse
change i.e., Arg91Leu does not yield a measurable activity of
TvLDH. The result was verified by molecular modeling and
in vitro functional characterization. This conversion showed that
MDH-LDH barrier has been broken in at least one direction.
This also highlighted the role of some important residue for
selection of catalysis of a substrate. Phylogenetic reconstructions
showed that members of the MDH and LDH families form
separate monophyletic lineages probably arose from early gene
duplication (Wu et al., 1999). Similarly, studies suggest that
evolution of (Cryptosporidium parvum) lactate dehydrogenase
from malate dehydrogenase arose by gene duplication. Ancestral
sequence reconstruction technique is useful to study these
evolutionary paths (Madern et al., 2004).
Another enzyme, aspartate aminotransferases are the most
extensively studied vitamin B-6 containing enzyme. These
are homodimeric enzymes that catalyze amino group transfer
between acidic amino acids, aspartate and glutamate, and their
corresponding 2-oxo acids. The triple mutation at its substrate-
binding site leads to increased rate of L-aspartate β-decarboxylase
activity to transaminase activity by 25 million-fold. In order to
elucidate both the structural basis of the functional properties
and course of the molecular evolution, molecular dynamics, and
crystal studies are performed (Graber et al., 1999). Similarly,
directed molecular evolution was done by mutating 17 amino
acids residues of enzyme aspartate aminotransferases in E. coli.
This had resulted in six-fold increase in activity for non-native
substrate i.e., valine. The remodeled enzyme had altered subunit
interface, and a shift in the enzyme domain. These results clearly
demonstrate the importance of the cumulative effects of residues
remote from the active site and present a new line of approach to
redesign enzymes (Oue et al., 1999).
Molecular dynamics and homology data also identified the
critical residues of tyrosine phenol lyase (TPL), an enzyme
involved in the β-elimination of tyrosine. Double mutations at
R100T and V283R are responsible for switching the substrate
specificity of TPL from L-tyrosine to dicarboxylic amino
acids in Citrobacter freundii. These mutations increased its
β-elimination activity toward dicarboxylic acids by four-fold
without destroying its catalytic apparatus. Thus, this experiment
gave a novel enzyme dicarboxylic amino acid β-lyase, which is
not found in nature. From this study, it can be concluded that
these enzymes originated from region-specific catalysts, which
first specialized for reaction specificity and then for substrate
specificity (Mouratou et al., 1999).
Site directed mutagenesis has been routinely used to
redesign enzymes, but the achievement in this technique
relies basically on the availability of 3-D structure protein
maps. Others techniques that are based on cross-referencing
substrate structure and comparisons with protein alignment
data, were also used. Choline acetyltransferases reversibly
transfer acetyl group between acetyl-coA and choline. After
site-directed mutagenesis the mutant enzyme have more
affinity for carnitine rather than choline. Thus, novel enzyme
called carnitine/choline acetyltransferase was obtained (Cronin,
1998). Likewise, catalytic efficiency of cholesterol oxidase from
Streptomyces and Brevibacterium, was also studied by site
directed mutagenesis and found that efficiency was increased in
the mutant S379T toward cholesterol and pregnenolone. These
findings provide ideas for designing more efficient enzyme which
can be clinically useful for cholesterol estimation (Toyama et al.,
2002).
A well-known industrial biocatalyst Glutaryl acylase (GA),
belongs to the N-terminal hydrolase class of hydrolytic enzymes
and show wide substrate specificity. CA (cephalosporin C
acylase) and GAs are members of the glutaryl acylase family
that specifically use CephC as their substrate. GA undergoes
a two-step reaction to yield cephalosporin and CA undergoes
only one step reaction to yield cephalosporin. CAs isolated from
Pseudomonas strains has very low activity for biotechnological
use. By using protein engineering approach based on combined
use of error-prone PCR mutagenesis, molecular modeling, site
saturation and site-directed mutagenesis, the glutaryl acylase
from Pseudomonas N176 has been mutated (A215αY-H57βS-
H70βS and H57βS-H70βS-L154βY). These enzyme variants have
100-fold increase in specificity constant for CephC (Conti et al.,
2014).
In addition to the alteration in the enzymes action, artificial
mutation can also alter the proteins for non-catalytic function.
Streptavidin and biotin is themodel system to study structure and
thermodynamic properties of high affinity receptor complexes
with its ligand. Biotin binding sites were redesigned in such a way
that the major structural motifs of the natural streptavidin-biotin
complex are preserved. This was done by changing amino acid
residues deep in the biotin-binding pocket to reduce the biotin-
binding affinity considerably without disturbing the binding
affinities for biotin analogs. Thus, a mutant of streptavidin was
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made which has greater binding specificity to 2-iminobiotin than
to its natural ligand biotin. This approach could also be useful for
in vivo targeting applications (Reznik et al., 1998).
Alteration in Coenzyme Specificity of
Enzyme
Cofactor specificity can also be altered by using techniques
like site-directed mutagenesis, DNA shuﬄing etc. The enzyme
lactate dehydrogenase has a specific cofactor NAD+. Using DNA
shuﬄing method, many mutants were made by substitution
at cofactor binding sites. A consensus library was made
to study cofactor specificity of Bacillus stearothermophilus
lactate dehydrogenase. A triple mutant was selected which had
decreased specificity for NAD+ and increased for NADP+. Thus,
an enzyme with change in cofactor was made without decrease
in its catalytic activity (Flores and Ellington, 2005). Similarly,
the NAD-dependent D-lactate dehydrogenase from Lactobacillus
bulgaricus had also been modified to display 40-fold shift of
coenzyme specificity from NADH to NADPH (Bernard et al.,
1995).
Similar experiments were also done in different organisms to
change the cofactor specificity. Malate dehydrogenase (MDH)
of Streptomyces coelicolor (ScMDH) was altered by site-directed
mutations in the Rossman fold region to change its cofactor
specificity from NADH to NADPH. The coenzyme specificity
(Kcat/Km) of the mutant enzyme was examined and found to be
shifted 2231.3-fold toward NADPH (Ge et al., 2014). Similarly,
in Thermus thermophilus, Thermus flavus, and Thermococcus
kodakarensis replacement of specific amino acids in Rossman fold
of NADH dependent lactate dehydrogenase changed its cofactor
from NADH to NADPH (Nishiyama et al., 1993; Tomita et al.,
2006a; Morimoto et al., 2014).
Xylose reductase (NADPH) and xylitol dehydrogenase
(NADH) of Pichia stipiti are involved in the catabolism of
xylose and for ethanol production from it. As the cofactors
of both these enzymes are different, redox imbalance occurs.
To solve this problem, site directed mutagenesis was done at
Lys21 in xylose reductase. Both K21A and K21A/N272Dmutants
preferred NADH over NADPH. Thus, a complete reversal of
coenzyme specificity toward NADH and improved catalytic
efficiency were achieved for this enzyme (Zeng et al., 2009).
In Candida tenuis, similar experiments (single mutant K274R,
K274M, K274G, S275A, N276D, R280H, and double mutant
K274R-N276D) were done to change the cofactor specificity of
xylose reductase (Petschacher et al., 2005).
Likewise, some residues of glutamate dehydrogenase of
Peptostreptococcus asaccharolyticus and Clostridium symbiosum
has been mutated, due to which catalytic efficiency toward
NADPH and NADP+ was increased by several folds, respectively
(Griffin and Engel, 2011). Formate dehydrogenase from Candida
boidinii (CboFDH) is known to catalyse the oxidation of formate
anion to carbon dioxide with concomitant reduction of NAD+
to NADH. It is highly specific to NADH and virtually fails
to catalyze the reaction with NADPH, but substitution at
Asp195Gln/Tyr196His position causes shift of cofactor specificity
from NADH to NADPH (Andreadeli et al., 2008). In isocitrate
dehydrogenase from E. coli, site-directed mutagenesis was
used to introduce five substitutions (Lys344Asp, Tyr345Ile,
Val351Ala, Try391Lys, Arg395Ser) in its adenosine binding
pocket that shifts the coenzyme specificity from NADP to NAD
(Chen R. et al., 1995). Studies also suggest that a mutation
in phenylacetaldehyde dehydrogenase mutation at F180T in
lactaldehyde dehydrogenase increases its specificity to NADP+
that also increased enzyme’s catalytic activity (Rodríguez-Zavala,
2008).
Same approach was applied to mutate various other
enzymes like nitrate reductase, carbonyl reductase etc.
which have been highlighted in Table 1(Shiraishi et al.,
1998; Morikawa et al., 2005). Microbial production of 1,
3-propanediol has been considered as a competitor to the
traditional petrochemical routes. Site directed mutagenesis
of 1, 3-propanediol oxidoreductase at Asp48 residue relaxes
the cofactor specificity of 1, 3-propanediol toward NADH
and NADPH, thereby increasing enzyme efficiency (Ma et al.,
2010). NADPH-dependent hydroxybenzoate hydroxylase from
Pseudomonas fluorescens was also subjected to site directed
mutagenesis that increases its cofactor specificity for NADH.
This was the first report on the coenzyme reversion of a
flavoprotein aromatic hydroxylase (Eppink et al., 1999).
Change in the Catalytic Activity of the
Enzyme
Genetic as well as chemical technologies offer tremendous
scope of modifying the basic characteristics of enzymes, e.g.,
activity, stability, thermal sensitivity etc., to enhance their
performance and to make them more suitable for industrial
as well as research applications. Aspartate aminotransferases
have central role in amino acid metabolism. Out of 13 random
mutations, six mutations (Table 1) contributed maximum to
the increased activity. Only six amino acids of the enzyme
were directly interacting with substrate and results showed that
directed molecular evolution is a powerful technique for enzyme
redesigning if an adequate selection system is applied (Yano et al.,
1998).
Tyrosine phenol lyase of microbial origin from C. freundii
uses pyridoxal 5′ phosphate as cofactor and catalyzes the
β-elimination of L-tyrosine to produce phenol and ammonium
pyruvate. The substitution of Asn185Ala results in formation
of a mutant, which has decreased affinity for substrate due
to destability of quinonoid structure, formed between them
(Barbolina et al., 2000). Similarly, Tyr71Phe was substituted in
Tyrosine phenol- lyase and as a result no detectable activity
for β-elimination of L-tyrosine was observed and also decreased
activity for other substrate was observed (Chen H. Y. et al., 1995).
Similarly, Asp124Thr and His448Phe mutations in tryptophan
indole-lyase of Proteus vulgaris, have little or no β-elimination
activity with L-Tyr or 3-fluoro-L-Tyra substrate, but retain
significant elimination activity with S-(o-nitro phenyl)-L-
cysteine, S-alkyl-L-cysteines, and β-chloroalanine (Demidkina
et al., 2002). In E. coli site-saturation mutagenesis was done and
many mutants were made by substituting the active site loop
residues. Out of those mutants only some of the substitution
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mutations increased β–galactosidase activity that is discussed in
the Table 1 (Geddie and Matsumura, 2004).
THERMODYNAMICS OF THE IN VITRO
DESIGN OF ENZYME
In continuation of above discussion, it is also important to study
the thermodynamic parameters like 1G, 1Cp, 1H involved in
the evolutionary path of these enzymes. Using thermodynamic
divergence of evolutionary path of mesophilic and thermophilic
Ribonuclease H1 from their common ancestor has been traced
(Hart et al., 2014). Analyzing its mutants enormous amount
of information about the critical positions in enzyme-substrate
selectivity can be collected. This is useful in finding their
evolution mechanisms i.e., how these enzymes evolved from
their ancestors using ancestral sequence reconstruction etc.
(Hart et al., 2014). Directed evolution technology to select an
enzyme with desired characteristics is one of the earliest and
successful methods such as half-life (t1/2) and activity (kcat) of
a cold-adapted Lipase B isolated from Candida antarctica were
significantly improved from 8 to 211 min and 84 min−1 to 1900
min−1, respectively.
CONCLUSIONS
Combined computational and in vitro evolution approaches
can be used for the study of evolution of novel bioactivity in
the natural enzymes as well as redesigning of the function of
the enzyme. DNA shuﬄing, site-saturation mutagenesis, and
site-directed mutagenesis are used can be used to redesign
the active site of an enzyme, which can alter its efficiency.
Artificial alteration of enzyme can be very useful in changing
the catalytic efficiency of enzymes, cofactor specificity, and
substrate specificity. Many new enzymes that do not occur
naturally can also be developed, which are more efficient. Using
these approaches, enzymes can be engineered according to the
requirement. For example, if there is defect in any enzyme, the
existing related enzyme or isozymes could be engineered in such
a way so that it can work in place of defected enzyme. Moreover,
the evolutionary relation and thermodynamic system drifts over
evolutionary time can also be studied.
FUTURE PROSPECTS
Engineered enzymes revolution has been brought about after the
discovery of extremophiles, organisms surviving, and thriving
in extreme environmental conditions like high temperature,
low temperature, high salt, and pH etc. Preliminary studies
with extremophile enzymes have provided the researchers vital
information about the mechanisms of their adaption of the
extreme environments and different catalytic activity. These
studies revealed the biochemical and structural features of
these enzymes, which facilitated scientists to engineer the
mesophilic enzymes to attain thermo- or cryo-stability. Similarly,
engineered thermophilic and psychrophilic enzymes attain
substrate specificity and activity of mesophilic enzymes and vice
versa. For example, thermostable hydrolases (used in starch,
food, pharmaceutical, leather, and textile industries), chitinases
(used in food, cosmetics, pharmaceuticals, agrochemicals related
industries), and phytases (release phosphorus from the phytate
are used in animal feed); and cryostable lipases, proteases,
phytases, glucanases, and xylanases are used with animal
feed; pectinases and xylanases are used in starch hydrolysis
at low temperatures; lipases and proteases used in detergent
and cleaning industry; lipases are being used in biofuel and
energy producing industry etc. Similarly, research activities can
also result in the development and production of numerous
engineered enzymes with application in industrial processes,
therapeutics and household products including food industry,
biodiesel, and bioremediation.
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